KMT2A and leukemia: The majority of leukemias expressing MECOM were driven by MLL rearrangements (MLLr) (59.7%), with other notable rearrangements being NUP98 fusions and MECOM fusions, confirming previously described subgroup specific patterns of MECOM expression37 (supplemental Figure 3A).